In vivo horizontal gene transfer of the carbapenemase OXA-48 during a nosocomial outbreak

Clinical Infectious Diseases

Volumn 60, Issue 12, 2015, Pages 1808-1815

  Göttig, Stephan ^a   Gruber, Teresa M ^a   Stecher, Bärbel ^b,c   Wichelhaus, Thomas A ^a   Kempf, Volkhard A J ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

^c German Center for Infection Research   (Germany)

Author keywords

lactamases; Low complexity microbiota mice; St666; Transconjugation

Indexed keywords

AMIKACIN; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; AZTREONAM; CARBAPENEMASE; CEFEPIME; CEFOTAXIME; CEFTAZIDIME; CEFUROXIME; CIPROFLOXACIN; COLISTIN; COTRIMOXAZOLE; DORIPENEM; ERTAPENEM; FOSFOMYCIN; GENTAMICIN; IMIPENEM; LEVOFLOXACIN; MEROPENEM; OXA 48 PROTEIN; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; SULBACTAM; TIGECYCLINE; TOBRAMYCIN; UNCLASSIFIED DRUG; BACTERIAL DNA; BETA LACTAMASE;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL STRAIN; BACTERIUM CONJUGATION; BACTERIUM ISOLATE; BLOODSTREAM INFECTION; CLONAL VARIATION; CONTROLLED STUDY; EPIDEMIC; ESCHERICHIA COLI; FEMALE; GALLERIA MELLONELLA; HORIZONTAL GENE TRANSFER; HOSPITAL INFECTION; HUMAN; IN VITRO STUDY; IN VIVO STUDY; KLEBSIELLA PNEUMONIAE; LARVA; MALE; MICROBIOLOGICAL EXAMINATION; MINIMUM INHIBITORY CONCENTRATION; MOUSE; MULTILOCUS SEQUENCE TYPING; NONHUMAN; PLASMID; PNEUMONIA; PRIORITY JOURNAL; URINARY TRACT INFECTION; ANIMAL; ANTIBIOTIC RESISTANCE; CROSS INFECTION; DRUG EFFECTS; GENETICS; KLEBSIELLA INFECTION; MICROBIOLOGY; MIDDLE AGED;

AGED; ANIMALS; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; CROSS INFECTION; DNA, BACTERIAL; ESCHERICHIA COLI; FEMALE; GENE TRANSFER, HORIZONTAL; HUMANS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MALE; MICE; MIDDLE AGED; MULTILOCUS SEQUENCE TYPING; PLASMIDS;

EID: 84940671893     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/civ191     Document Type: Article

References (26)

1. Dimou V, Dhanji H, Pike R, Livermore DM, Woodford N. Characterization of Enterobacteriaceae producing OXA-48-like carbapenemases in the UK. J Antimicrob Chemother 2012; 67:1660-5.
2. Nordmann P, Gniadkowski M, Giske CG, Poirel L, Woodford N, Miriagou V; European Network on Carbapenemases. Identification and screening of carbapenemase-producing Enterobacteriaceae. Clin Microbiol Infect 2012; 18:432-8.
3. Poirel L, Héritier C, Tolün V, et al. Emergence of oxacillinase-mediated resistance to imipenem in Klebsiella pneumoniae. Antimicrob Agents Chemother 2004; 48:15-22.
4. Poirel L, Bonnin R, Nordmann P. Genetic features of the widespread plasmid coding for the carbapenemase OXA-48. Antimicrob Agents Chemother 2012; 56:559-62.
5. Potron A, Poirel L, Nordmann P. Derepressed transfer properties leading to the efficient spread of the plasmid encoding carbapenemase OXA-48. Antimicrob Agents Chemother 2014; 58:467-71.
6. Carrër A, Poirel L, Yilmaz M, et al. Spread of OXA-48-encoding plasmid in Turkey and beyond. Antimicrob Agents Chemother 2010; 54:1369-73.
7. Mathers AJ, Hazen KC, Carroll J, et al. First clinical cases of OXA-48- producing carbapenem-resistant Klebsiella pneumoniae in the United States: the "menace" arrives in the new world. J Clin Microbiol 2013; 51:680-3.
8. Lascols C, Peirano G, Hackel M, Laupland KB, Pitout JD. Surveillance and molecular epidemiology of Klebsiella pneumoniae isolates that produce carbapenemases: first report of OXA-48-like enzymes in North America. Antimicrob Agents Chemother 2013; 57:130-6.
9. Poirel L, Potron A, Nordmann P. OXA-48-like carbapenemases: the phantom menace. J Antimicrob Chemother 2012; 67:1597-606.
10. Goren MG, Carmeli Y, Schwaber MJ, Chmelnitsky I, Schechner V, Navon-Venezia S. Transfer of carbapenem-resistant plasmid from Klebsiella pneumoniae ST258 to Escherichia coli in patient. Emerg Infect Dis 2010; 16:1014-7.
11. Won SY, Munoz-Price LS, Lolans K, Hota B, Weinstein RA, Hayden MK, Centers for Disease Control and Prevention Epicenter Program. Emergence and rapid regional spread of Klebsiella pneumoniae carbapenemase- producing Enterobacteriaceae. Clin Infect Dis 2011; 53:532-40.
12. Higgins PG, Dammhayn C, Hackel M, Seifert H. Global spread of carbapenem- resistant Acinetobacter baumannii. J Antimicrob Chemother 2010; 65:233-8.
13. Dewhirst FE, Chien CC, Paster BJ, et al. Phylogeny of the defined murine microbiota: Altered Schaedler flora. Appl Environ Microbiol 1999; 65:3287-92.
14. Stecher B, Denzler R, Maier L, et al. Gut inflammation can boost horizontal gene transfer between pathogenic and commensal Enterobacteriaceae. Proc Natl Acad Sci U S A 2012; 109:1269-74.
15. Stecher B, Chaffron S, Käppeli R, et al. Like will to like: Abundances of closely related species can predict susceptibility to intestinal colonization by pathogenic and commensal bacteria. PLoS Pathog 2010; 6: e1000711.
16. Power K, Wang J, Karczmarczyk M, et al. Molecular analysis of OXA-48-carrying conjugative IncL/M-like plasmids in clinical isolates of Klebsiella pneumoniae in Ireland. Microb Drug Resist 2014; 20:270-4.
17. Desbois AP, Coote PJ. Wax moth larva (Galleria mellonella): An in vivo model for assessing the efficacy of antistaphylococcal agents. J Antimicrob Chemother 2011; 66:1785-90.
18. Thomas RJ, Hamblin KA, Armstrong SJ, et al. Galleria mellonella as a model system to test the pharmacokinetics and efficacy of antibiotics against Burkholderia pseudomallei. Int J Antimicrob Agents 2013; 41:330-6.
19. Insua JL, Llobet E, Moranta D, et al. Modeling Klebsiella pneumoniae pathogenesis by infection of the wax moth Galleria mellonella. Infect Immun 2013; 81:3552-65.
20. Doi Y, Park YS, Rivera JI, et al. Community-associated extendedspectrum -lactamase-producing Escherichia coli infection in the United States. Clin Infect Dis 2013; 56:641-8.
21. Sáez-López E, Guiral E, López Y, et al. Characterization of CTX-M-14 and CTX-M-15 producing Escherichia coli strains causing neonatal sepsis. Microb Drug Resist 2014; 20:281-4.
22. Tumbarello M, Viale P, Viscoli C, et al. Predictors of mortality in bloodstream infections caused by Klebsiella pneumoniae carbapenemaseproducing K. pneumoniae: importance of combination therapy. Clin Infect Dis 2012; 55:943-50.
23. Daikos GL, Petrikkos P, Psichogiou M, et al. Prospective observational study of the impact of VIM-1 metallo-beta-lactamase on the outcome of patients with Klebsiella pneumoniae bloodstream infections. Antimicrob Agents Chemother 2009; 53:1868-73.
24. Navarro-San Francisco C, Mora-Rillo M, Romero-Gomez MP, et al. Bacteraemia due to OXA-48-carbapenemase-producing Enterobacteriaceae: A major clinical challenge. Clin Microbiol Infect 2013; 19: E72-9.
25. Daikos GL, Markogiannakis A. Carbapenemase-producing Klebsiella pneumoniae: (when) might we still consider treating with carbapenems? Clin Microbiol Infect 2011; 17:1135-41.
26. Daikos GL, Tsaousi S, Tzouvelekis LS, et al. Carbapenemase-producing Klebsiella pneumoniae bloodstream infections: lowering mortality by antibiotic combination schemes and the role of carbapenems. Antimicrob Agents Chemother 2014; 58:2322-8.